Market Value6,848,327,000
Total Holdings124
File Date2022-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
LJPC / La Jolla Pharmaceutical Co.
EPIX / ESSA Pharma Inc.
ISO / IsoPlexis Corp
SRRK / Scholar Rock Holding Corporation
BMEA / Biomea Fusion, Inc.
OYST / Oyster Point Pharma Inc
TELA / TELA Bio, Inc.
ISEE / IVERIC bio Inc
LUNG / Pulmonx Corporation
GLUE / Monte Rosa Therapeutics, Inc.
LSAQ / LifeSci Acquisition II Corp
MSAC / Medicus Sciences Acquisition Corp - Class A
CUTRQ / Cutera, Inc.
RACB / Research Alliance Corp II - Class A
FVAM / 5:01 Acquisition Corp.
URGN / UroGen Pharma Ltd.
RCOR.WS / Renovacor, Inc. Warrants, enti Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11.50 per whole share
MDXG / MiMedx Group, Inc.
SMFR / Sema4 Holdings Corp - Class A
TNDM / Tandem Diabetes Care, Inc.
PRCT / PROCEPT BioRobotics Corporation
OMIC / Singular Genomics Systems, Inc.
RXST / RxSight, Inc.
DNAY / Codex DNA Inc
ATHA / Athira Pharma, Inc.
AADI / Aadi Bioscience, Inc.
NEO / NeoGenomics, Inc.
SRPT / Sarepta Therapeutics, Inc.
MGNX / MacroGenics, Inc.
NSTG / NanoString Technologies, Inc.
PTGX / Protagonist Therapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
CERE / Cerevel Therapeutics Holdings, Inc.
SOPH / SOPHiA GENETICS SA
BOLT / Bolt Biotherapeutics, Inc.
CTMX / CytomX Therapeutics, Inc.
SUMMIT HEALTHCRE ACQUISTN CO / UNIT 06/03/2026 (G8566R128)
DRNA / Dicerna Pharmaceuticals Inc
INMD / InMode Ltd.
612657106 / Montes Archimedes Acquisition Corp., Class A
PROF / Profound Medical Corp.
KYG5960S1241 / Medicus Sciences Acquisition Corp.
UTRS / Minerva Surgical, Inc.
/ VENTYX BIOSCIENCES INC
/ Nautilus Biotechnology Inc
AFIB / Acutus Medical, Inc.
CVRX / CVRx, Inc.
BLI / Berkeley Lights Inc
GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
CLSD / Clearside Biomedical, Inc.
TNGX / Tango Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
CSTL / Castle Biosciences, Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
PNT / POINT Biopharma Global Inc.
XGN / Exagen Inc.
ARYE / ARYA Sciences Acquisition Corp V - Class A
BLSA / BCLS Acquisition Corp - Class A
SPY / SPDR S&P 500 ETF
HLXA / Helix Acquisition Corp - Class A
BLU / Bellus Health Inc
APVO / Aptevo Therapeutics Inc.
ADVM / Adverum Biotechnologies, Inc.
PRQR / ProQR Therapeutics N.V.
QTRX / Quanterix Corporation
ZY / Zymergen Inc
INKT / MiNK Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
OSUR / OraSure Technologies, Inc.
ITOS / iTeos Therapeutics, Inc.
APEN / Apollo Endosurgery Inc
RARE / Ultragenyx Pharmaceutical Inc.
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
OM / Outset Medical, Inc.
BNR / Burning Rock Biotech Limited - Depositary Receipt (Common Stock)
MRTX / Mirati Therapeutics, Inc.
ABUS / Arbutus Biopharma Corporation
MASS / 908 Devices Inc.
VINC / Vincerx Pharma, Inc.
OLK / Olink Holding AB (publ) - Depositary Receipt (Common Stock)
ARWR / Arrowhead Pharmaceuticals, Inc.
MXCT / MaxCyte, Inc.
TWST / Twist Bioscience Corporation
RCEL / AVITA Medical, Inc.
JNCE / Jounce Therapeutics Inc
TXG / 10x Genomics, Inc.
TNYA / Tenaya Therapeutics, Inc.
CCCC / C4 Therapeutics, Inc.
JNJ / Johnson & Johnson
NYXH / Nyxoah SA
PYXS / Pyxis Oncology, Inc.
CHAQ / Chardan Healthcare Acquisition 2 Corp
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
CLDX / Celldex Therapeutics, Inc.
APYX / Apyx Medical Corporation
SGHT / Sight Sciences, Inc.
RXDX / Prometheus Biosciences Inc
PMVP / PMV Pharmaceuticals, Inc.
AXNX / Axonics, Inc.
LABP / Landos Biopharma, Inc.
DMTK / DermTech, Inc.
GH / Guardant Health, Inc.
AGEN / Agenus Inc.
ILMN / Illumina, Inc.
MIRO / Miromatrix Medical Inc
VCEL / Vericel Corporation
AXSM / Axsome Therapeutics, Inc.
AVDL / Avadel Pharmaceuticals plc
TMO / Thermo Fisher Scientific Inc.
ACET / Adicet Bio, Inc.
ARYD / ARYA Sciences Acquisition Corp IV
RGNX / REGENXBIO Inc.
ROIV / Roivant Sciences Ltd.
GMED / Globus Medical, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
MRUS / Merus N.V.
AKYA / Akoya Biosciences, Inc.
FULC / Fulcrum Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
PEN / Penumbra, Inc.
STOK / Stoke Therapeutics, Inc.
NTRA / Natera, Inc.
MASI / Masimo Corporation
ESTA / Establishment Labs Holdings Inc.
MIST / Milestone Pharmaceuticals Inc.
RNA / Avidity Biosciences, Inc.
GHRS / GH Research PLC
IMUX / Immunic, Inc.
IMTX / Immatics N.V.
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
ALNY / Alnylam Pharmaceuticals, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
PTCT / PTC Therapeutics, Inc.
RLMD / Relmada Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)